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Abstract 
The inhibition of pathogens entry through the blockade of DC-SIGN (dendritic cell-specific intercellular 
adhesion molecule-3-grabbing nonintegrin) receptor at early stages of infection is an efficient strategy 
for testing new antiviral agents. Although a variety of models have been reported, one of the main 
problems is achieving adequate size and multivalency to mimic natural systems such as viruses or other 
pathogens.  In this regard, hexakis-adducts of [60]fullerene allow a full control of size and multivalency 
while maintaining a globular shape. For this purpose,tridecafullerenes decorated with 120 peripheral 
carbohydrate subunits have been efficiently synthesized from hexakis-adducts of [60]fullerene in one 
synthetic step by using the copper-catalyzed azide–alkyne cycloaddition (CuAAC) click-chemistry 
methodology. These so-called 'superballs' decorated with 120 mono-saccharides (mannose or galactose) 
moieties are water soluble, allowing the study of their biological properties. An infection assay has been 
employed to test the ability of these compounds to inhibit the infection of cells by an artificial Ebola 
virus. The results obtained in these experiments show that the 'superballs' are potent inhibitors of cell 
infection by this artificial Ebola virus with IC50s in the sub-nanomolar range. This implies more than a 
three-orders-of-magnitude increase of activity in comparison to the hexakis-adduct containing just 12 
mannoses and only 18-fold less activity than virus-like glycodendrinanoparticles with diameters of 
roughly 32 nm displaying up to 1620 glycans. 
  
Multivalency is a general and efficient tool used by nature for achieving strong interactions in a 
reversible manner. At the molecular level, multivalent interactions have the advantage of 
enhancing drastically the binding between molecules when compared with the monovalent 
binding.1 
A remarkable example from nature where multivalency plays a significant role is the interaction 
between viruses and bacteria with their respective host cells. In particular, DC-SIGN (dendritic 
cell-speciﬁc intercellular adhesion molecule-3-grabbing non-integrin) receptor is one of the 
most important pathogen recognition receptors. This lectin efficiently recognizes in a 
multivalent manner saccharides containing mannoses and fucoses from glycoproteins.2 In this 
regard, it is well established that protein−carbohydrate interactions are a key issue in a variety 
of biological processes, but since the aﬃnity of simple glycans for their respective receptors is 
often weak, multivalent interactions typically occur. An important open challenge of research 
nowadays is the better understanding and practical use of multivalency. Actually, in a broader 
sense, glycobiology is currently a field of research where chemically inspired approaches and 
strategies are producing significant advances.3 
It is well-known, however, that some viruses are able to escape from processing by the immune 
defense by using DC-SIGN as an entry point to infect the cell. Therefore, the inhibition of 
pathogens entry by blocking this receptor at the early stages of infection represents a valuable 
strategy for the design of new antiviral agents. In order to address this challenge, a variety of 
different multivalent scaffold architectures have been synthesized, all of them endowed with 
multiple carbohydrates.4 Design of these glyco-conjugates typically requires a multivalent 
central scaffold or core covalently connected to the carbohydrate epitopes decorating the 
periphery. Thus, glyco-clusters showing the carbohydrate units directly connected to the core, 
glyco-dendrimers connected through a dendritic structure and glyco-polymers involving a 
polymeric backbone have intensively been investigated in recent years.5, 6, 7, 8, 9 
Fullerenes also have been employed as a biocompatible scaffold for the multivalent 
presentation of ligands, given the possibility of multiple functionalization on their convex 
surface. In particular, hexakis-adducts of [60]fullerene with a Th-symmetrical octahedral addition 
pattern have a unique three-dimensional structure which allows the introduction of six one-type 
or mixed-types addends.10, 11 Such derivatives can be obtained in one synthetic step by the 
addition of malonates to C60, but it has been somehow limited by the low yields resulting with 
bigger malonates, as the reaction is very sensitive to steric effects.12 We have recently developed 
a procedure based on a click-chemistry approach which provides hexakis-adducts with twelve 
alkyne or azide terminal groups in high yields from simple malonates.13, 14 These hexakis-adducts 
can be easily and efficiently functionalized by using the copper-catalyzed azide–alkyne 
cycloaddition (CuAAC) reaction allowing the introduction of twelve functional groups 
simultaneously in a regioselective and efficient way. Since these hexakis-adducts show an 
octahedral arrangement of equally separated addends located on the [60]fullerene periphery in 
a globular topology, they constitute a very attractive platform for the study of multivalent 
interactions with lectins, with important advantages such as the better biocompatibility of the 
carbon central core, the globular geometry of the functional groups and the ease and versatile 
chemical functionalization. 
Thus, we have recently reported the syntheses of [60]fullerene hexakis-adducts endowed with 
different carbohydrate units in the periphery. Depending upon the starting sugar derivatives 
employed (monomer, dimer or trimer) 12, 24 and up to 36 monosaccharides have been 
introduced on the periphery of the fullerene central core in a straightforward manner.14, 15, 16, 17  
Remarkably, some of the aforementioned glycofullerenes have proven to show interesting bio-
medical applications.18 Thus, a significant multivalent effect has been observed in the inhibition 
profile of a [60]fullerene hexakis-adduct endowed with 12 iminosugar units towards different 
glycosidases.16 On the other hand, fullerene hexakis-adducts bearing 12 mannoses on the 
periphery behave as inhibitors of FimH, a bacterial adhesin.19 Furthermore, studies carried out 
on hexakis-adducts of [60]fullerene endowed with 12, 24 and 36 mannoses have shown a 
multivalent effect in the interaction with Concanavalin A,15 and acting as efficient inhibitors of 
cell infection by Ebola pseudotyped viral particles.20 These preliminary studies reveal that 
fullerenes are adequate platforms for the multivalent presentation of carbohydrates, thus 
paving the way to the covalent linkage of a wide variety of different bio-active molecules in a 
multivalent manner and a singular and less-explored globular topology. 
In this work, we have synthesized unprecedented and giant molecules showing a globular 
topology and formed by hexakis-adduct of hexakis adducts of [60]fullerene, carrying out the 
fastest dendrimeric growth reported up to now, with the introduction of 120 sugar units in one 
synthetic step by using the highly efficient CuAAC click-chemistry methodology. The synthesis of 
hexakis-adducts of hexakis-adducts of [60]fullerene with an octahedral addition pattern has 
previously been reported. However, as macrocyclic bis-malonates were used, this procedure 
allows the synthesis of heptafullerenes with tunable properties.21, 21 22, 23 In contrast, our click-
chemistry approach yields tridecafullerenes in which the central [60]fullerene is covalently 
connected to twelve [60]fullerenes, each of them endowed, in turn, with ten monosaccharides. 
To confirm the proposed structures, we have also carried out a thorough structural study 
involving a variety of techniques (FTIR, 1H NMR, 13C-NMR, DLS, TEM, XPS). Remarkably, biological 
studies reveal that the new giant glycofullerenes exhibit a very strong inhibition of cell infection 
by Ebola pseudotyped viral particles with IC50 values in the sub-nanomolar range. 
Synthesis 
The synthesis of the glycofullerene superballs has been carried out as depicted in Figures 1-3. 
Although these molecules (17a-c) may appear difficult to obtain at a first glance, mainly due to 
their size and molecular complexity, their synthesis is straightforward and, most importantly, 
easily reproducible affording the final compounds in good overall yields. Furthermore, as 
discussed below, purification of the samples including the required removal of copper for further 
biological studies are carried out easily since these compounds (17a,b), after column filtration, 
are precipitated in the reaction medium and pure samples showing highly reproducible 
biological essays are obtained. 
With the aim of studying the effect of the size and/or steric congestion of these superballs on 
the biological properties, two different and complementary synthetic strategies have been 
simultaneously developed to obtain final products with different spacers in between the central 
fullerene core and the peripheral carbohydrate substituted fullerene appendages. In both cases, 
the synthesis relies on the grafting of clickable A10B macromonomers onto a compact C60 hexa-
adduct scaffold bearing twelve terminal alkyne units. The preparation of macromonomer 9 is 
depicted in Figure 1. Esterification of alcohol 1 with ethylmalonyl chloride followed by reaction 
of the resulting malonate (2) with C60 under Bingel conditions gave methanofullerene 3. 
Subsequent treatment of 3 with an excess of malonate 4, CBr4, and DBU in o-dichorobenzene 
(ODCB) gave building block 5 to which mannose derivative 6 was clicked. Importantly, the TMS-
protected alkyne unit is not reactive under these conditions and intermediate 7 was thus 
obtained in a good yield. Finally, compound 7 was desilylated in situ with tetrabutylammonium 
fluoride (TBAF) to generate the corresponding terminal alkyne and reaction with a large excess 
of diazide 8 provided the desired macromonomer 9 in 87% yield.  
 Figure 1. Synthesis of azidofullerene  derivative 9. Reagents and conditions. (i) ethylmalonyl 
chloride, pyridine, CH2Cl2, 0 to 25°C, 1 h (99%); (ii) C60, I2, DBU, 25 °C, Tol, 16 h (49%); (iii) CBr4, 
DBU, 25 °C, ODCB, 72 h (67%); (iv) CuSO4.5H2O, sodium ascorbate, THF/H2O, 100°C (MW), 2 h 
(91%); (v) 8 (19 equiv.), CuSO4.5H2O, sodium ascorbate, TBAF, THF/H2O, 80°C (MW), 1.5 h (87%). 
 
The synthesis of macromonomers 15a-b starts from monoadduct 10 resulting from the Bingel 
nucleophilic cyclopropanation of C60 with 6-bromohexyl ethyl malonate (Figure 2).25 To obtain 
the [5:1]- hexaadduct 12, a tenfold excess amount of di(pent-4-yn-1-yl) malonate and a 50-fold 
excess of carbon tetrabromide were added in the presence of DBU as the base. Flash 
chromatography purification provided hexaadduct 12 as a red solid. Different carbohydrate 
azides (mannose, galactose) were then linked to C60 by the CuAAC reaction, employing 
CuBr·S(CH3)2 as the catalyst and sodium ascorbate as the reducing agent in the presence of a 
piece of metallic Cu, to yield derivatives 14a-b. The nucleophilic substitution of bromine by azide 
was carried out with an excess of sodium azide under microwave heating, thus giving versatile 
building blocks 15a-b.  
 
 Figure 2. Synthetic pathway to azidofullerene  derivatives 15a-b. Reagents and conditions. (i) 
di(pent-4-yn-1-yl) malonate, CBr4, DBU, 20 °C, Tol, 72 h (49%); (ii) 2-azidoethyl α-D-
mannopyranoside for 14a (or 2-azidoethyl α-D-galactopyranoside for 14b), CuBr·S(CH3)2, sodium 
ascorbate, Cu0, DMSO, 72 h (14a: 86%; 14b: 86%); (iii) NaN3, 70 °C (MW), DMSO, 3 h (15a: 84%; 
15b: 81%). 
The azide-containing macromonomers 9 and 14a-b were then clicked to symmetric alkyne 
derivative 1614 under CuAAC conditions. Superballs 17a-c substituted with up to 120 
monosaccharide units were thus obtained with yields over 70% (Figure 3). Remarkably, 
derivatives 17a-b have been obtained in only three synthetic steps from easily accessible 
reactives and avoiding the use of protecting groups.  
Although the three tridecafullerenes 17a-c contain the same number of monosaccharides, 
compound 17c has a larger spacer between the central fullerene moiety and the peripheral 
carbohydrate functionalized fullerenes. This longer spacer affects the flexibility and the size of 
the compound and can favor the accessibility and availability of the carbohydrate ligands to 
interact with the receptor, which could have an important influence on the biological activity.20 
It is important to note, however, that the aforementioned synthetic approaches allow 
synthesizing fullerene derivatives from malonates endowed with alkyl chains of variable length 
through a first Bingel cyclopropanation and a subsequent CuAAC reaction. This synthetic 
strategy affords hexakis-adducts with long chains connecting the fullerenes and carbohydrates 
since their direct preparation from suitably functionalized malonates bearing long chains 
typically occur with remarkably low yields.10 
 
 Figure 3. Synthetic scheme for tridecafullerenes 17a-c. Reagents and conditions. For 
compounds 17a-b: (i) 15a-b, CuBr·S(CH3)2, sodium ascorbate, Cu0, DMSO, 25°C, 48 h [17a (from 
15a): 73%; 17b (from 15b): 79%]. For compound 17c: (i) 9, CuSO4.5H2O, sodium ascorbate, 
THF/H2O, 80°C (MW), 2 h (76%). 
Characterization of these superballs was carried out by standard spectroscopic techniques. 
Thus, FTIR spectra do not show the presence of neither azide group (typical signal observed at 
2097 cm-1) nor alkyne ( 2117 cm-1) (See the Supplementary Information). The molecular ion 
peak of these compounds could not be detected. Actually the transfer of such high molecular 
weight glycoclusters in the gas phase during the MALDI-TOF MS analysis is very difficult. 
Moreover, both the sugars and the fullerene hexaadduct moieties give rise to high level of 
fragmentation.26 The unambiguous structural characterization of 17a-c was, however, greatly 
facilitated by their high symmetry. Indeed, 13C NMR spectroscopy was particularly helpful for 
the characterization of hexakis-adducts of [60]fullerene, as only two signals are usually observed 
for the sp2 carbons of C60, evidencing the octahedral symmetry of the fullerene core. As a typical 
example, the 13C NMR spectrum of compound 17a is depicted in Figure 4. In this case, only two 
sp2 carbons are observed in the spectra (δ  145.4 and 141.6), where we can also distinguish the 
two different kinds of triazole rings present in the derivative (at δ  146.9 and 123.3 the carbons 
of the outer triazole rings and at δ  146.4 and 122.9 the carbons of the inner triazole rings). In 
addition, only one signal is detected for all the carbonyl groups (δ  163.8) and the sp3 carbons 
of the C60 (δ  69.3), while the malonate bridgehead carbons present in the structure are 
observed at δ  45.2. 
 
Figure 4. 13C NMR spectrum of tridecafullerene 17a in DMSO-d6. Assignment of the most 
representative signals is depicted. 
 
Additional characterization was achieved by DLS analysis (H2O, 0.01 mg/mL and 0.1 mg/mL), 
where, regardless the concentration used, we have found two or three main size distributions 
for 17a-c (Supplementary Figure 1). This is compatible with a weakly cooperative aggregation of 
17a-c in water. The first, around 5-6 nm, must correspond to only one molecule, while the 
second, at 120-150 nm and third, 200 nm, show the aggregation of several molecules. In 
DMSO (0.1 mg/mL) (Supplementary Figure 2), although most of the molecules show no 
aggregation, the presence of aggregates of different sizes and, especially, very large aggregates, 
is also detected. The tendency to form aggregates was also confirmed by the broadening of the 
13C NMR spectrum recorded in D2O when compared to the one recorded in DMSO-d6 (see 
Supplementary Information). 
The TEM images of freshly prepared samples reveal the presence of small spherical particles, 
corresponding to a few or even just one molecule (4 nm), independently of whether the 
concentration is 0.01 mg/mL or 0.1 mg/mL, in good agreement with the experimental findings 
in DLS analyses (Figure 5 and Supplemntary Figure 3). 
 
 
Figure 5. TEM images of tridecafullerene 17a. a) TEM images of compound 17a upon deposition 
of a 0.01 mg/mL solution in H2O. b) Detail of a particle corresponding apparently to one 
molecule. c) Width profile of the particle shown in b). 
X-ray photoelectron spectroscopy (XPS) was additionally employed to confirm the composition 
of the sugar balls. This surface technique allows the identification of the atoms present on the 
molecule together with their chemical state and their relative abundance. The survey spectra of 
superball 17a (Supplementary Figure 4) displays the C 1s, O 1s and N 1s features as expected, 
with no additional spectroscopy signatures of possible impurities. Moreover, the high resolution 
N 1s core level spectrum (Supplementary Figure 4, inset right) was composed of two different 
components with a 1:2 ratio of the integrated areas, the one located at 400.3 eV is related to 
one nitrogen atom of the triazole ring (N-N-N) and the other centered at 398.8 eV is attributed 
to the other two nitrogen atoms attached to carbon atoms (C-N).27 The absence of a well 
resolved peak around 405.0 eV demonstrates the lack of the electron-deficient nitrogen of the 
azide group in the final compound.28, 29 The composition of compounds 17b and 17c has also 
been ascertained by their respective XPS analyses which showed the presence of the expected 
elements, according to their relative abundance (see Supplementary Figure 4 and 
Supplementary Table 1). 
 
Biological studies 
A number of molecules including DC-SIGN have been proposed as receptors for Ebola virus, 30, 
31, 32 although DC-SIGN is not the main receptor in case of Ebola virus, it is thought to play a 
significant role in the cell entrance of this infectious agent in significant cell populations such as 
dendritic cells,30, 33 thus facilitating early viral dissemination.  Therefore, DC-SIGN can function 
as a good model of studying the first steps of pathogenesis of Ebola virus and screening the 
antiviral strategies based on DC-SIGN targeting compounds for prevention and treatment 
purposes. DC-SIGN recognizes mannosylated and fucosylated oligosaccharides presented in a 
multivalent manner on the surface of several pathogen envelope glycoproteins. Thus the 
preparation of multivalent carbohydrate systems is necessary for the efficient interaction with 
this receptor as well as for the effective competition with the natural ligands. In this study we 
have evaluated the inhibitory effect of giant globular multivalent glycofullerenes in the 
experiment of direct infection of Jurkat DC-SIGN+ with pseudotyped viral particles presenting 
Ebola virus glycoprotein GP1. These globular multivalent systems are water soluble and show 
no cytotoxicity in cell lines allowing the study of their potential biological function in preventing 
viral infection. All multivalent compounds were checked for the possibility of blocking DC-SIGN 
receptor in 6 independent experiments. The results of blocking DC-SIGN receptor by different 
compounds were shown as a function of concentration. The 50% of inhibition of the infection 
was calculated with the 95% confidence intervals. As a control, infection with DC-SIGN-
independent VSV glycoprotein-pseudotyped lentiviral particles was performed in the same 
conditions. 
 
The results obtained in the infection experiment revealed the dependence of the inhibition 
effect on mannoses. Compound 17b displaying 120 galactoses, as expected, was not able to 
inhibit the infection process mediated by DC-SIGN. Compounds envisaged with 120 mannose-
based residues (17a and 17c) showed very strong antiviral activity at picomolar to nanomolar 
concentrations. Compound 17a could effectively block Ebola virus infection at low nanomolar 
concentrations with the IC50 of 20.375 nM (95%CI = 14.63 – 28.37 nM). Compound 17c was 
almost one order of magnitude more potent at inhibiting the infection process showing the IC50 
of 667 pM (95%CI = 411.1 pM – 1.08 nM) (Figure 6).  
 
Previous inhibition studies using the same infection model and fullerenes displaying up to 36 
mannoses show relative inhibitor potency (RIP) values at least two orders of magnitude 
smaller.19 Moreover, huge virus-like particles (VLP) with a radius of 16 nm and up to 1640 
mannoses33 were 18 fold less potent than compound 17c described in this work (see 
Supplementary Table 2). These results have confirmed the efficiency of these systems to interact 
with DC-SIGN and to compete with Ebola virus glycoprotein-pseudotyped particles during their 
entry into target cells.” 
 
The cytotoxic effect of multivalent glycofullerenes was verified by a cell proliferation assay using 
the Cell Titer 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega). Notably, there 
was not any appreciable cytotoxic effect of compounds 17a-c at the concentration used in the 
infection experiments (see Figure S5). 
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Figure 6. Biological study of tridecafullerenes (17a-c). Inhibition of infection with EBOV or VSV 
GP-pseudotyped lentiviral particles of Jurkat DC-SIGN+ cells using 17a (blue), 17b (green) and 
17c (red). In the cis-infection experiments 2.5x105Jurkat DC-SIGN+ were challenged with 5000 
TCID of recombinant lentiviral particles. Results represent the mean of 6 independent 
experiments +/- SEM.  
 
Conclusions 
 
In summary, we have synthesized for the first time giant globular multivalent glycofullerenes in 
which the central C60 core is covalently connected to twelve hexakis-adducts of C60, thus forming 
the first tridecafullerenes reported so far. Since each peripheral fullerene is endowed with ten 
monosaccharides, a total of 120 carbohydrates are decorating the periphery of the 
supermolecule which represents the fastest dendrimer growth ever reported, affording 
molecular weights as high as 56 KDa. 
The synthesis of non-symmetric hexakis-adducts (7, 9, 14a,b, 15a,b) as well as the formed 
tridecafullerenes (17a-c) have been accomplished by using CuAAC click-chemistry reactions in 
an efficient manner. In this way, very sophisticated molecular ensembles have been efficiently 
produced in a minimum of synthetic steps and their apparent structural complexity is not a 
limitation for their applications. Despite the high molecular weights, the new molecules have 
been characterized by standard spectroscopic techniques (FTIR, 1H NMR, 13C NMR) as well as by 
DLS, XPS and TEM. Interestingly, NMR spectroscopy unambiguously reveals the high degree of 
symmetry (Th) in hexakis-adducts. 
 
Tridecafullerenes are soluble in water and, therefore, they have been tested as globular 
multivalent systems to inhibit lectin-mediated viral infection processes in cellular assays. In 
particular, compounds 17a-c have been used to test their ability to inhibit the infection of cells 
by an artificial Ebola virus. Remarkably, tridecafullerenes efficiently block Ebola virus infection 
in the range of sub-nanomolar concentrations. These values surpass in three orders of 
magnitude (two if the number of mannoses is considered) to that of hexakis-adducts endowed 
with 12 mannoses.  
 
The aforementioned results reveal fullerenes as a very appealing platform for the study of 
multivalent interactions with significant advantages such as their biocompatibility and globular 
presentation. Furthermore, the compounds now reported pave the way to the introduction of 
dendritic dimers and trimers of monosaccharides as well as the use of disaccharides to 
significantly improve the scope of the biological applications of tridecafullerenes. 
 
METHODS 
Production of recombinant viruses 
Recombinant viruses were produced in 293T cells. The viral construction was pseudotyped with 
Zaire Ebola virus (ZEBOV) envelope glycoprotein (GP) or vesicular stomatitis virus envelope GP 
(VSV-G) and expressed luciferase as a reporter of the infection.34 One day (18-24 h) before 
transfection, 5 x 106 293T were seeded onto 10 cm plates. Cells were cultured in DMEM medium 
supplemented with 10% heat-inactivated FBS, 25 mg Gentamycin, 2 mM L-glutamine. Few 
minutes before transfection, the medium on transfection plates was changed to 9 ml DMEM 
and chloroquine was added to 25µM final concentration. Transfection reaction with all reagents 
at room temperature (RT) was prepared in 15 ml tubes: 183 µl of 2M CaCl2, 500 ng of EBOV-GP 
or 2 µg of VSV-G, 21 µg of pNL4-3 luc35, 1300 µl of H2O. Next, 1.5 ml of 2xHBS (Hepes Buffer 
Saline) pH 7.00 was added quickly to the tubes and bubbled for 30 seconds. HBS/DNA solution 
was gently dropped onto medium. After 8 hours of incubation at 37º C with 5% CO2, medium on 
transfection plates was changed to 10 ml DMEM and once again one day after transfection to 7 
ml DMEM. Transfection supernatants were harvested after 48 h, centrifuged at 1200 rpm for 10 
minutes at RT to remove cell debris, and stored frozen at -80° C.33, 36 
Ebola virus infection experiments  
Infection was performed on Jurkat cells (T-lymphocyte cell line) expressing receptor DC-SIGN on 
its surface. Since Ebola virus does not infect T-lymphocytes, its entry is absolutely dependent on 
DC-SIGN for infection of Jurkat cells.30, 37 
Jurkat DC-SIGN+ cells (2.5 x 105) were plated into each well of 96-well plate. Cells were incubated 
at RT for 20 minutes with the carbohydrate-based compounds and then challenged with 5000 
TCID (Tissue Culture Infective Dose) of recombinant viruses. After 48 h of incubation cells were 
washed twice with PBS and assayed with the Luficerase Assay System (Promega, Madison, WI). 
The range of concentrations tested for compounds 17a-c was 1 pM – 10 µM. As a control, 
experiment of infection with VSV-G pseudoviruses was performed in the same conditions. 
Infection with VSV-G is independent of the presence of DC-SIGN receptor. 
Statistical analysis 
The values of percentage of inhibition of the infection presented on the graph correspond to the 
mean of 6 independent experiments with error bars corresponding to the standard errors of the 
mean. The IC50s values were estimated using GraphPad Prism v6.0 with a 95% confidence 
interval and settings for normalize dose-response curves. 
Cytotoxicity assay 
The Cell Titer 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega) was used. Jurkat 
DC-SIGN+ (5 x 105 cells/well) were seeded into wells of 96-well plate and left cultured in the 
presence of different concentrations of glycofullerenes for the time of infection assay. After 48 
h, the proliferation cell assay was performed. Briefly, the 2 ml MTS solution was mixed with 100 
µl of PMS solution. The mix MTS/PMS in a volume of 20 µl was pipetted into each well of the 96-
well assay plate containing 100 µl of cells in culture medium. The plate was incubated for 2 h at 
37º C in a humidified 5% CO2 atmosphere. After incubation time, the absorbance at 490 nm was 
recorded using an ELISA plate reader. As a control of toxicity, the viability of cells in the presence 
of 0.1% Triton-X100 was measured. The results of the assay were presented as the percentage 
of cells viability, which was calculated from the absorbance at 490 nm as compared to 
absorbance shown by cells incubated without addition of glycofullerenes representing 100 % of 
cells viability. 
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